ArticleMolecular medicine (Cambridge, Mass.)2021

Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry.

Rodrigo R R Duarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.